Fuente: Labiotech Lugar: Podcast Today, we are with Andy Parker, CEO of Step Pharma, and we'll discuss a targeted approach to cancer an the future of precision oncology.
The post Turning cancer cell dependencies into targeted therapies appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.